Citigroup’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$500K Buy
69,376
+65,869
+1,878% +$423K ﹤0.01% 3547
2025
Q4
$19.8K Sell
3,507
-2,685
-43% -$14.6K ﹤0.01% 4874
2025
Q3
$38.2K Sell
6,192
-46,182
-88% -$270K ﹤0.01% 4570
2025
Q2
$255K Buy
52,374
+34,291
+190% +$121K ﹤0.01% 3950
2025
Q1
$66.9K Buy
18,083
+428
+2% +$1.83K ﹤0.01% 4790
2024
Q4
$70.6K Buy
17,655
+1,045
+6% +$5.74K ﹤0.01% 4973
2024
Q3
$116K Buy
16,610
+11,569
+229% +$93.8K ﹤0.01% 4701
2024
Q2
$28.6K Sell
5,041
-42,671
-89% -$382K ﹤0.01% 4885
2024
Q1
$636K Buy
+47,712
New +$446K ﹤0.01% 3403
2022
Q4
Sell
-98
Closed -$1K 5939
2022
Q3
$1K Sell
98
-56
-36% -$565 ﹤0.01% 5685
2022
Q2
$1K Sell
154
-228
-60% -$2.37K ﹤0.01% 6087
2022
Q1
$7K Sell
382
-1,332
-78% -$23.5K ﹤0.01% 5703
2021
Q4
$45K Buy
1,714
+1,245
+265% +$38K ﹤0.01% 5121
2021
Q3
$17K Buy
469
+33
+8% +$1.4K ﹤0.01% 5300
2021
Q2
$24K Buy
436
+65
+18% +$4.29K ﹤0.01% 5203
2021
Q1
$31K Sell
371
-260
-41% -$28.8K ﹤0.01% 4991
2020
Q4
$72K Buy
631
+243
+63% +$15.4K ﹤0.01% 5792
2020
Q3
$12K Sell
388
-65
-14% -$2.49K ﹤0.01% 6512
2020
Q2
$20K Sell
453
-71
-14% -$2.95K ﹤0.01% 6623
2020
Q1
$19K Sell
524
-51
-9% -$2.52K ﹤0.01% 6737
2019
Q4
$38K Sell
575
-950
-62% -$105K ﹤0.01% 6538
2019
Q3
$237K Buy
1,525
+2
+0.1% +$226 ﹤0.01% 5018
2019
Q2
$131K Buy
1,523
+26
+2% +$2.83K ﹤0.01% 5626
2019
Q1
$207K Sell
1,497
-3,240
-68% -$812K ﹤0.01% 5065
2018
Q4
$1.9M Buy
4,737
+4,500
+1,899% +$2.12M ﹤0.01% 2726
2018
Q3
$168K Buy
237
+123
+108% +$77.3K ﹤0.01% 5426
2018
Q2
$61K Sell
114
-2
-2% -$615 ﹤0.01% 6133
2018
Q1
$13K Buy
+116
New +$39.2K ﹤0.01% 6942

Other funds holding SLDB